ICER

The Institute for Clinical and Economic Review (ICER) is a trusted non-profit organization that evaluates evidence on the value of medical tests, treatments and delivery system innovations and moves that evidence into action to improve the health care system. To accomplish this goal ICER performs analyses on effectiveness and costs; develops reports using innovative methods that make it easier to translate evidence into decisions; and, most distinctively, fills a critical gap by creating sustainable initiatives with all health care stakeholders that can align efforts to use evidence to drive improvements in both practice and policy. Through all its work, ICER seeks to play a pivotal role in creating a future in which collaborative efforts to move evidence into action provide a foundation for a more effective, efficient, and just health care system.


ICER Weekly View 02-16-18

From the desk of Mitchell Stein Good morning. Calling this a busy time for drug news would be like calling Mount Everest a little hill. Following last week’s budget deal, we had a Council on Economic Advisors drug price report and the Administration’s proposed budget. We also had several large […]


ICER Weekly View 02-09-18

From the desk of Mitchell Stein Good morning. The government is back open. What? It was open when you went to bed and you don’t know what I’m talking about? While you were sleeping, the government shut down and then opened back up. No biggie. What is a biggie is […]


ICER Weekly View 02-02-18

From the desk of Mitchell Stein Good morning. Lots going on inside the beltway this week with the State of the Union, the new HHS Secretary was sworn in and the resignation of the CDC Director – don’t worry, but don’t worry, I’ve got you covered. Keep reading all the […]


ICER Weekly View 01-26-18

From the desk of Mitchell Stein Good morning. Government shutdowns, over $20 billion in deals, cost figure controversy new Secretary of HHS, and gene therapy meeting; it’s been a busy year week so let’s get right to it. This morning we’ll take a look at: ICER in the news – Midwest […]


ICER Weekly View 01-19-18

From the desk of Mitchell Stein Good morning. I am fascinated by the group of hospitals banding together to form a non-profit generic drug firm. Will it have an impact? Will the mere threat of its existence serve as a check on prices? Can it address chronic shortages of older […]


ICER Weekly View 01-12-18

From the desk of Mitchell Stein Good morning. This week J.P Morgan took over San Francisco with their annual Healthcare Conference. I’ll devote Weekly View In-depth to coverage of the event. Congress also returned to DC resulting in lots of Beltway news. Here’s today’s full rundown: ICER in the news […]


ICER Weekly View 01-05-18

From the desk of Mitchell Stein Good morning. Happy New Year and welcome back to those who have been on vacation (and thanks to those who stuck with me last week). Just as the new year was ramping up, the East Coast was hit with a storm. Here at Weekly […]


ICER Weekly View 12-29-17

From the desk of Mitchell Stein Good morning. I hope you have all been enjoying your holidays and hopefully short (or non-existent) work-week. Personally, I’ve been spending too much time thinking about the future of health coverage, but that’s just me. Today we have some news to cover, but I’ll […]


ICER Weekly View 12-22-17

From the desk of Mitchell Stein Good morning. To start the day, allow me to wish you all happy holidays and happy New Year! For those taking next week off, enjoy! If you’re working, know that I’ll be here with you – providing news of the week and a look […]


!ICER Weekly View 12-15-17

From the desk of Mitchell Stein Good morning. The nation was on the edge of their seats this week as they awaited results which, one way or another, would have historical importance. I’m talking, of course, about how the new Star Wars movie would be received. The results are in, […]


ICER Weekly View 12-08-17

From the desk of Mitchell Stein Good morning.  Breaking news rocked the health policy world this week when the AP Styleguide tweeted they would consider changing their guidelines for the term “health care” from two words to one. What, you thought I was talking about something else? You can read […]


ICER Weekly View 12-01-17

From the desk of Mitchell Stein Good morning.  Last night saw a lot of activity on the floor of the Senate as they tried to revise the nation’s tax system on the fly.  While we don’t know what form today’s Senate tax bill will take, it’s fair to say it […]


ICER Weekly View 11-22-17

From the desk of Mitchell Stein Good morning.  We’re publishing early this week so that all of you can enjoy your turkey.   While it may be a short week, there’s no lack of news to discuss.  I hope everyone has a great holiday, but first, this (abbreviated) week we’ll look […]


ICER Weekly View 11-17-17

From the desk of Mitchell Stein Good morning.  The health policy community lost a titan this week.  Uwe Reinhardt, an economist whose insights were only matched by his wit, passed away.  If you’re involved in health care, even if you don’t realize it, you’ve come across his ideas.  Here’s one […]


ICER Weekly View 11-10-17

From the desk of Mitchell Stein Good morning.  So we had an election this week, and as always, there are those that are happy and those that are sad with the results. Regardless of your response, it is clear that, as put by Kaiser Health News, Health Care Galvanizes Voters.  From […]


ICER Weekly View 11-03-17

From the desk of Mitchell Stein Good morning.  A lot of activity inside the Beltway this week, but before we get started, I’d like to point out a piece of news outside our usual area.  “Unbelievable” study results were released yesterday (‘Unbelievable’: Heart Stents Fail to Ease Chest Pain) showing […]


ICER Weekly View 10-27-17

From the desk of Mitchell Stein Good morning. It’s that time again, no, not another ACA repeal bill; tomorrow is National Take Back Prescription Drug Day. Sites will be set up across the country to drop off unneeded and expired medications. You can find a local drop-off site here.  But […]


ICER Weekly View 10-20-17

From the desk of Mitchell Stein Good morning.  We’ll start today with a pleasant distraction.  While chemistry is not strictly within the sphere of this newsletter, since all the drugs we discuss are comprised of elements, I’m going to go for it…  Earlier in the summer the magazine Science published Elemental Haiku, […]


ICER Weekly View 10-13-17

From the desk of Mitchell Stein Good morning.  It’s Friday the 13th, so my sympathy to those of you with triskaidekaphobia.  Actually, given the ACA chaos we are all waking up to, my sympathy to all of us.  But we’re not here to talk about that, on the pharma front […]


ICER Weekly View 10-06-17

From the desk of Mitchell Stein Good morning. With no repeal bill taking up bandwidth, lots of drug pricing news this week. (Although with expected CMS action on the birth control mandate today and an executive order on association plans next week, I don’t expect the ACA lull to last.)  This […]